Nina Lin, MD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases

MD, Harvard Medical School



Dr. Nina Lin is a physician scientist who is engaged in HIV translational research. Her research is focused on understanding the effect of chronic HIV infection on aging of the immune system and chronic inflammation. She is the PI on several clinical trials, including being a co-Chair of ACTG A5325 and A5220s, to evaluate interventions which may improve or alter the clinical course of chronic HIV infection. Her research while at MGH/BWH had been on understanding HIV-1 coreceptor usage in subtype C infection and the factors associated with its switching. She is the Director of the BU Infectious Disease Clinical Research Unit (CRU) where several HIV and/or infectious diseases clinical studies are being conducted.


Impact of smoking and its cessation on systemic and airway immune activation
08/15/2016 - 06/30/2018 (Co-PI)
PI: Avrum Spira, MD
Boston Medical Center Corporation NIH NIDA
5R01DA042685-02


Impact of smoking and its cessation on systemic and airway immune activation
08/15/2016 - 06/30/2021 (PI)
NIH-NIDA
1R01DA042685-01

REPRIEVE A5332 Cardiac MRI (substudy): Mechanisms of Cardiac Dysfunction in HIV and the Effect of..
06/16/2017 - 03/31/2021 (PI)
Mass General Hosp NIH-NHLBI

MK-00036400001
01/10/2018 - 01/09/2021 (PI)
Merck

GS-US-380-4030: A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy
06/19/2017 - 06/19/2020 (PI)
Gilead Sciences

Phase III, randomized, multi center…switching to dolutegravir plus lamivudine in HIV-1
11/10/2017 - 11/10/2019 (PI)
GlaxoSmithKline

REPRIEVE A5332 Women's Ancillary Study (substudy)
03/01/2017 - 02/28/2019 (PI)
Brigham & Women's NIH-NIAID
5R01AI123001-03

Intensified antiretroviral therapy with raltegravir in acute HIV infection to limit establishment…
12/10/2014 - 12/31/2018 (PI)
Merck

Lifespan/Tufts/Brown Center for AIDS Research(CFAR): Core E
07/01/2017 - 06/30/2018 (PI)
Miriam Hospital NIH-NIAID

GS-US-380-1844: A Phase 3, Randomized, Double-Blind Study to Evaluate Switching from a Regimen
05/16/2016 - 05/31/2018 (PI)
Gilead Sciences

GS-US-366-1160: a Phase 3b, Randomized, Souble-Blind Study to Evaluate Switching from a Regimen
06/17/2015 - 05/31/2018 (PI)
Gilead Sciences

Showing 10 of 18 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Lin N, Gonzalez OA, Registre L, Becerril C, Etemad B, Lu H, Wu X, Lockman S, Essex M, Moyo S, Kuritzkes DR, Sagar M. Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants. EBioMedicine. 2016 Jun; 8:237-47.View Related Profiles. PMID: 27428434; PMCID: PMC4919596; DOI: 10.1016/j.ebiom.2016.04.040;.
     
  2. Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J, True W, Lin N, Toomey R, Eaves L. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry. 1998 Nov; 55(11):967-72. PMID: 9819064.
     

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 2 publications over 2 distinct years, with a maximum of 1 publications in 1998 and 2016

YearPublications
19981
20161
Contact for Mentoring:


650 Albany St Evans Biomed Research Ctr
Boston MA 02118
Google Map


Lin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department